An Open-label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506285-31-00

Acronym

GO41596

Enrollment

Registered

2024-04-15

Start date

2021-04-21

Completion date

Unknown

Last updated

2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally Advanced or Metastatic Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Italy, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026